Log In
Print
BCIQ
Print
Print this Print this
 

CP-870,893

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionMAb targeting CD40
Molecular Target CD40
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

VLST Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today